New COVID-19 boosters look more toxic than old ones

May explain low rates of acceptance. Adverse events for 2nd booster markedly higher for bivalent booster dose at 84.6% (95% CI 70.3-92.8%; 33/39) compared to the monovalent 51.4% (95% CI 35.9-66.6%; 19/37) vaccine (p=0.0028). High incapacitation rates for bivalent BA.4-BA.5 booster dose.

https://www.trialsitenews.com/a/bivalent-mrna-vaccines-high-rate-of-adverse-events-observational-study-at-university-hospital-wuerzburg-in-germany-4c4afad6

https://t.me/C19ExpertChannel/2229